Tag Archives: Prof. Gavin Giovannoni

Merck presented new data on efficacy and safety for investigational Cladribine Tablets at the American Academy of Neurology (AAN)

Posted on 2, May 2017 by

Subgroup analysis shows >80% reduction in the risk of disability progression with Cladribine Tablets vs placebo DARMSTADT, 02-May-2017 — /EuropaWire/ — Merck, a leading science and technology company, announced the presentation of new analyses of efficacy and safety data for … Read the full press release →

Posted in Germany, Healthcare, Pharma & Biotech

Tagged , , , , ,